Wealthfront Advisers LLC Incyte Corp Transaction History

Wealthfront Advisers LLC

$32.2 Billion
Q3 2024

A detailed history of Wealthfront Advisers LLC transactions in Incyte Corp stock. As of the latest transaction made, Wealthfront Advisers LLC holds 31,864 shares of INCY stock, worth $2.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,864

Previous 5,887 441.26%

Holding current value

$2.29 Million

Previous $356,000 491.57%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$57.33 - $68.61 $1.49 Million - $1.78 Million	25,977 Added 441.26%	31,864 $2.11 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $1.02 Million - $1.27 Million	-19,844 Reduced 77.12%	5,887 $356,000
Q1 2024 Apr 19, 2024	SELL	$56.55 - $66.59 $1.41 Million - $1.66 Million	-24,890 Reduced 49.17%	25,731 $1.47 Million
Q4 2023 Feb 09, 2024	BUY	$52.16 - $64.19 $670,568 - $825,226	12,856 Added 34.04%	50,621 $3.18 Million
Q3 2023 Nov 01, 2023	SELL	$57.77 - $65.93 $749,161 - $854,980	-12,968 Reduced 25.56%	37,765 $2.18 Million
Q2 2023 Aug 07, 2023	SELL	$60.95 - $75.51 $709,031 - $878,407	-11,633 Reduced 18.65%	50,733 $3.16 Million
Q1 2023 Apr 28, 2023	BUY	$70.23 - $86.01 $2.12 Million - $2.6 Million	30,200 Added 93.89%	62,366 $4.51 Million
Q4 2022 Feb 10, 2023	SELL	$67.18 - $84.11 $189,111 - $236,769	-2,815 Reduced 8.05%	32,166 $2.58 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $524,211 - $656,334	7,921 Added 29.27%	34,981 $2.33 Million
Q2 2022 Jul 20, 2022	BUY	$66.18 - $83.18 $600,914 - $755,274	9,080 Added 50.5%	27,060 $2.06 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $1.19 Million - $1.43 Million	17,980 New	17,980 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $194,336 - $237,776	-2,830 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $4,392 - $4,814	-55 Reduced 1.91%	2,830 $238,000
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $33,904 - $44,823	446 Added 18.29%	2,885 $234,000
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $250,536 - $303,163	-3,103 Reduced 55.99%	2,439 $212,000
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $281,071 - $362,415	-3,304 Reduced 37.35%	5,542 $497,000
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $656,196 - $963,594	8,846 New	8,846 $920,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $169,764 - $231,001	-2,687 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$73.04 - $95.72 $196,258 - $257,199	2,687 New	2,687 $235,000
Q3 2019 Oct 15, 2019	SELL	$72.82 - $86.52 $409,758 - $486,848	-5,627 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $217,251 - $262,108	2,955 Added 110.59%	5,627 $478,000
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $169,832 - $235,590	2,672 New	2,672 $230,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Incyte Corp Transaction History